 Predictive Oncology Inc has entered into definitive agreements to sell shares and units with multiple institutional investors that are expected to generate gross proceeds of 7.2 million, the company announced. In the first offering, the company will issue and sell more than 3.8 million shares at a price of 0.60 per share to several institutional investors for gross proceeds of 2.3 million. 